Cor Vasa 2007, 49(11):388-390

Tepenné revaskularizace myokardu

Petr Němec
Centrum kardiovaskulární a transplantační chirurgie, Brno, Česká republika

Published: November 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Němec P. Tepenné revaskularizace myokardu. Cor Vasa. 2007;49(11):388-390.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. New Engl J Med 2007;356:1030-9. Go to original source... Go to PubMed...
    2. Lagerquist B, James SK, Stenestrand U, Lindback J, Nilson T, Wallentin L, for the SCAAR study group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. New Engl J Med 2007; 356:1009-18. Go to original source... Go to PubMed...
    3. Mitka M. Heart groups issue advisories for reducing drug-eluting stent risks. JAMA 2007;297:797-8. Go to original source... Go to PubMed...
    4. Vojáček J. Pozdní trombózy lékových stentů - zanedbatelný problém nebo konec velké naděje? Racionální přístup k lékovým stentům. Cor Vasa 2007;6:209-11.
    5. Želízko M. Lékové stenty - kritický pohled na kritiku. Interv Akut Kardiol 2007;6:39-40.
    6. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005;16, 46:575-81. Go to original source...
    7. Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, Cosgrove DM. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004;78:2005-12. Go to original source... Go to PubMed...
    8. Sabik JF, Blackstone EH, Gillinov AM, Banbury MK, Smerida NG, Lytle BW. Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg 2006;131:90-8. Go to original source... Go to PubMed...
    9. Stevens LM, Carrier M, Perrault LP, et al. Single versus bilateral internal thoracic artery grafts with concomitant saphenous vein grafts for multivessel coronary artery bypass grafting: effects on mortality and event-free survival. J Thorac Cardiovasc Surg 2004;127:1408-15. Go to original source... Go to PubMed...
    10. Endo M, Nishida H, Tomizawa Y, Kasanuki H. Benefit of bilateral mammary artery grafts over single IMA graft for multiple coronary artery bypass grafting. Circulation 2001;104:2164-70. Go to original source... Go to PubMed...
    11. Hayward PAR, Hare DL, Gordon I, Matalanis G, Buxton BF. Which arterial conduit? Radial artery versus free right internal thoracic artery: Six-years clinical results of randomized controlled trial. Ann Thorac Surg 2007;84:493-7. Go to original source... Go to PubMed...
    12. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg 2004;77:93-101. Go to original source... Go to PubMed...
    13. Ferrari ER, von Segesser LK. Arterial grafting for myocardial revascularization: how better is it? Curr Opin Cardiol 2006;21:584-8. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes